Cargando…

Future targets for migraine treatment beyond CGRP

BACKGROUND: Migraine is a disabling and chronic neurovascular headache disorder. Trigeminal vascular activation and release of calcitonin gene-related peptide (CGRP) play a pivotal role in the pathogenesis of migraine. This knowledge has led to the development of CGRP(-receptor) therapies. Yet, a su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Hassany, Linda, Boucherie, Deirdre M., Creeney, Hannah, van Drie, Ruben W. A., Farham, Fatemeh, Favaretto, Silvia, Gollion, Cédric, Grangeon, Lou, Lyons, Hannah, Marschollek, Karol, Onan, Dilara, Pensato, Umberto, Stanyer, Emily, Waliszewska-Prosół, Marta, Wiels, Wietse, Chen, Hui Zhou, Amin, Faisal Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304392/ https://www.ncbi.nlm.nih.gov/pubmed/37370051 http://dx.doi.org/10.1186/s10194-023-01567-4

Ejemplares similares

Genetics of migraine: where are we now?
por: Grangeon, Lou, et al.
Publicado: (2023)

The sense of stopping migraine prophylaxis
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis
por: Onofri, Agnese, et al.
Publicado: (2023)

Subjective Sleep Quality and Sleep Architecture in Patients With Migraine: A Meta-analysis
por: Stanyer, Emily Charlotte, et al.
Publicado: (2021)

What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2023)

Mode and site of action of therapies targeting CGRP signaling
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2023)

CGRP in migraine
por: Tfelt-Hansen, Peer, et al.
Publicado: (2009)

CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016)

The unusual course of a migraine attack during COVID-19 infection — Case studies of three patients
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

Migraine and Sleep—An Unexplained Association?
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
por: Favoni, Valentina, et al.
Publicado: (2019)

Serotonin and CGRP in Migraine
por: Aggarwal, Milan, et al.
Publicado: (2012)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

CGRP and the Trigeminal System in Migraine
por: Iyengar, Smriti, et al.
Publicado: (2019)

Unmet Needs in Preventive Treatment of Migraine
por: Bentivegna, Enrico, et al.
Publicado: (2023)

Sinonasal symptoms in migraine without aura: results from the cross-sectional ‘Migraine in Poland’ study
por: Straburzynski, Marcin, et al.
Publicado: (2023)

Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort: Results from ‘Migraine in Poland’—a nationwide cross-sectional survey
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2023)

CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?
por: Kamm, Katharina
Publicado: (2022)

Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients?
por: Onan, Dilara, et al.
Publicado: (2022)

Blocking the CGRP Receptor: Differences across Human Vascular Beds
por: de Vries, Tessa, et al.
Publicado: (2023)

CGRP and migraine: neurogenic inflammation revisited
por: Geppetti, P., et al.
Publicado: (2005)

CGRP receptors and TRP channels in migraine
por: Geppetti, Pierangelo, et al.
Publicado: (2015)

CGRP as a Migraine Inducing Substance
por: Olesen, J., et al.
Publicado: (2001)

Dural Immune Cells, CGRP, and Migraine
por: Balcziak, Louis K., et al.
Publicado: (2022)

Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy
por: Scuteri, Damiana, et al.
Publicado: (2021)

Reaching the Nadir of Medication Overuse in Chronic Migraine
por: Onan, Dilara, et al.
Publicado: (2022)

Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine
por: Berman, Gary, et al.
Publicado: (2020)

Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
por: Raffaelli, Bianca, et al.
Publicado: (2023)

Debate: differences and similarities between tension-type headache and migraine
por: Onan, Dilara, et al.
Publicado: (2023)

Migraine therapeutics differentially modulate the CGRP pathway
por: Bhakta, Minoti, et al.
Publicado: (2021)

Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine—A Real-Life Study
por: Nowaczewska, Magdalena, et al.
Publicado: (2022)

Effect of Xiongmatang Extract on Behavioral and TRPV1-CGRP/CGRP-R Pathway in Rats With Migraine
por: Liu, Dingding, et al.
Publicado: (2022)

OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
por: Onan, Dilara, et al.
Publicado: (2022)

Refractory migraine profile in CGRP‐monoclonal antibodies scenario
por: Silvestro, Marcello, et al.
Publicado: (2021)

New Anti-CGRP Medications in the Treatment of Vestibular Migraine
por: Hoskin, Justin L., et al.
Publicado: (2022)

The Responses to CGRP in the Territory of the Posterior Cerebral Artery in Migraine
por: Visočnik, Darja, et al.
Publicado: (2022)

Shared and independent roles of CGRP and PACAP in migraine pathophysiology
por: Kuburas, Adisa, et al.
Publicado: (2023)

Nutrition and Calcitonin Gene Related Peptide (CGRP) in Migraine
por: Fila, Michal, et al.
Publicado: (2023)

Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor: Addition to the S1 guideline: Therapy of migraine attacks and prevention of migraine. Recommendations of the Germany Society of Neurology and the German Migraine and Headache Society
por: Diener, Hans-Christoph, et al.
Publicado: (2020)

Assessment of Visual and Brainstem Auditory Evoked Potentials in Patients with Hashimoto's Thyroiditis
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lmmn2r8g01kb2mrmtfus8m7j1a